189 filings
Page 5 of 10
8-K
shipwmcxk0vtc fwq
24 Dec 14
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
odixvwrv zxagjbo
30 Jul 14
Oxygen Biotherapeutics Announces Fiscal Year 2014 Financial Results
12:00am
8-K
4te6tet3w
4 Apr 14
Oxygen Biotherapeutics Inc., Announces the Appointment of
12:00am
8-K
08pzt
21 Mar 14
Oxygen Biotherapeutics Announces Proposed Public Offering
12:00am
8-K
6remjrmm
6 Mar 14
Oxygen Biotherapeutics Inc. Provides an Update on Communication
12:00am
8-K/A
ugm5z
22 Jan 14
Financial Statements and Exhibits
12:00am
8-K
c86sh4wnqup
23 Dec 13
Departure of Directors or Certain Officers
12:00am
8-K/A
u2nq9hb
20 Dec 13
Submission of Matters to a Vote of Security Holders
12:00am
8-K
8hx717w
9 Dec 13
Submission of Matters to a Vote of Security Holders
12:00am
8-K
vclbcu1pmta xsal
19 Nov 13
Oxygen Biotherapeutics Closes the Acquisition of
12:00am
8-K
d1rrmi 0u
8 Nov 13
Oxygen Biotherapeutics Receives $6 Million in Net Proceeds from Warrant Exercises
12:00am
8-K
iyltaurm3hhq3zdbw
25 Oct 13
Oxygen Biotherapeutics Signs Agreement to Acquire Phase 3, FDA Fast Track Product to Pursue Potential $600 Million Cardiovascular Market
12:00am
8-K
837 z7d2p
26 Aug 13
Entry into a Material Definitive Agreement
12:00am
8-K
cui4nuakkj2km 4egw
13 Aug 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
uvo83vw4tqpv
31 Jul 13
Other Events
12:00am
8-K
2vbzj2
25 Jul 13
Oxygen Biotherapeutics Prices Public Offering
12:00am
8-K
1q9 envqewl8pk0rj
27 Jun 13
Oxygen Biotherapeutics Reports Financial Results for Fiscal Year 2013
12:00am
8-K
1yyzan6 adbn
16 May 13
Oxygen Biotherapeutics Receives Favorable NASDAQ Listing Decision
12:00am
8-K
7tiy9ufdzzec8vgpq
15 May 13
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
gtij6
1 May 13
Submission of Matters to a Vote of Security Holders
12:00am